ArticleTransplantation direct2026
Optimizing Lung Transplant Logistics Using Controlled Hypothermic Preservation to Extend Ischemic Time.
Article in Transplantation direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Effective organ preservation before transplantation is pivotal for successful outcomes but can be limited by logistics. Organs are primarily preserved by flushing with a cold solution and storing on ice, then transplanted within 8 h of procurement. Controlled hypothermic preservation (CHP) at 4-8 °C has increasingly been used to extend ischemic times. Here we compared early outcomes of transplants using CHP (n = 41) and traditional preservation on ice (n = 41). Methods: Our institution used LUNGguard, a CHP device by Paragonix, for the extension of ischemic time to optimize operating room (OR), transplant team, and recipient logistics. We evaluated 1-y mortality, primary graft dysfunction, length of stay, time to liberation from mechanical ventilation, and time on oxygen support. Results: There were no differences in patient outcomes between storage on ice and CHP. In selected cases, extending ischemic times using CHP allowed for additional organ procurement as well as improved OR logistics. Conclusions: In our experience, CHP has been shown to be a safe and effective method of extending ischemic times in donor lungs, allowing for increased donor acceptance and improved OR efficiency. This supports a growing body of evidence favoring a shift from ice to CHP as the standard for donor lung storage in cases of extended ischemic time.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.